(Part 7 of 9) Ann Tsukamoto, Ph.D., spoke at the Scientific Writer’s Seminar, a workshop presented on September 17, 2008 at CIRM headquarters in San Francisco. Tsukamoto is the Chief Operating Officer at Stem Cells, Inc., a Palo Alto based company that has begun a stem cell based human clinical trial for the treatment of Batten disease. Tsukamoto reviewed the process of getting the therapy approved for the clinical trial.
Pluristem Therapeutic Inc. (NasdaqCM: PSTI) is a bio-therapeutics company dedicated to the commercialization of allogeneic (non-personalized) cell therapy products derived from the human placenta, an organ that has traditionally been considered medical waste after childbirth. The company uses its PLX products for the treatment of a variety of ischemic and autoimmune disorders where current therapies are unavailable or inadequate. Pluristem’s adherent stromal cells are and a non-embryonic, non-controversial source of cells.
For all of carmels videos visit her web site www.msstemcell.com Her web site describes in detail the treatment. Carmel’s video journey of being treated for Multiple Sclerosis with a stem cell bone marrow transplant that has proven record 75%-82% in registered peered reviewed studies that have appeared in legitmate journals such as the lancet neurological journal. Trails have a proven record of placing the disease in remission and halting the progression of the disease. Reversing the neurological damage caused by the disease. This treatment halts the progression by 100%. This is instead of current treatments that has a 40% chance of slowing the disease progress and if the patient responds to treatment they are unable to tell you how much the progress will be slowed down by. Carmel web site descibes how she obtained the treatment and how she gained access to employment insurance that covered all expenses of her treatment and living expenses. Carmel wants to empower MS suffer’s and thier loved ones with information that she found difficult to obtain from oraganisations setup for MS sufferers and medicial institutions.
In excess of 7 million people worldwide die of coronary heart disease each year. Only one-third of these heart attack victims recover completely. The remainder suffer the consequences of myocardial infarction and its ill fated remodeling process, resulting in chronic congestive heart failure. This malady alone is the leading cause of hospital admissions in the United States. New breakthroughs in stem cell therapy and tissue engineering have promised to reverse this dismal outcome by card
Defense Department’s AFIRM to fund Stratatech’s Phase IIb clinical trial of StrataGraft tissue
Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that the Defense Department’s Armed Forces Institute of Regenerative Medicine will fund the Phase IIb clinical trial of the company’s flagship StrataGraft living human skin substitute tissue. Read more on News-Medical-Net
This digital document is an article from Family Practice News, published by International Medical News Group on September 15, 2001. The length of the article is 1431 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
This digital document is an article from The Register-Guard (Eugene, OR), published by The Register Guard on April 23, 2003. The length of the article is 1680 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Caring as byproduct of blood.(Health)(Eugene man donates his stem cells in hop
Cell Therapy Foundation Calls for Additional Research, Extensive Clinical Trials
Court Action Halting Embryonic Stem Cell Research Highlights Need for Significant Adult Stem Cell Trials and Funding; Adult Stem Cell Treatment Studied in Trials Involving Patients with Heart Disease, Vascular Disorders, and Multiple Sclerosis Read more on PRWeb via Yahoo! News
Cell Therapy Foundation Calls for Additional Research, Extensive Clinical Trials
Some of the most promising medical research conducted to treat diseases of the brain, heart, and circulatory system is moving too slowly to help millions of patients, according to the Cell Therapy Foundation, which advocates the use of adult stem cells to dramatically impact and improve the condition of patients who suffer from a variety of conditions. Read more on PR Newswire via Yahoo! Finance
Researchers recommend action to reverse federal court decision on embryonic stem cell research ban
Against a backdrop of some of the world’s most sophisticated biological research labs, Rep. Steve Israel (D-Huntington) this morning issued a challenge to his colleagues in Congress immediately upon their return from summer recess, he urged, they should pass legislation that would reverse a recent Federal court decision that has brought embryonic stem cell research in the U.S. to a screeching … Read more on News-Medical-Net
Op saves life of sickle cell boy
A BAHRAINI teenager born with sickle cell anaemia has made a full recovery after undergoing pioneering surgery in Singapore. Abdulhameed Sogra, 13, is now completely free of the condition and looking forward to going back to school after his sister donated bone marrow required for the procedure. Read more on Gulf Daily News
The theory of a stem-cell origin of cancer is neither ground breaking nor earth shattering. Many prominent investigators have established the foundation for this concept and performed the vital experiments to support its validity and merit. The purpose of this book is to illustrate how this theory may completely transform our current views and perspective about cancer. It is anticipated that the variety of ramifications of a stem-cell origin of cancers will be embraced by the medical resea
Women of all ages continue to wage war against cellulite. The unsightly bulges and dimpled skin that results from trapped fat cells under the skins surface can prevent even the leanest woman from achieving a sculpted and toned appearance. Since diet and exercise rarely eliminate the problem, surgery or cellulite treatments may be the only effective way to lose the cellulite for good. Angel Legs is a revolutionary STEM-CELL Based formula that is an approved cellulite treatment that is safe non-in
(out of reviews)
